INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Cohance Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543064	ISIN Demat INE03QK01018	Book Value 60.86	NSE Symbol COHANCE	Dividend Yield (%) 0	Market Cap (₹ Cr.) 37,866.50	P/E 107.24	EPS 9.23	Face Value 1

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	1,093.51	1,051.35	1,330.08	1,320.22	1,009.72
Sale of Products	1,055.05	1,024.12	1,283.85	1,253.37	949.33
Sale of Services	13.26	9.94	37.01	53.64	46.13
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	25.20	17.29	9.22	13.21	14.25
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	1,093.51	1,051.35	1,330.08	1,320.22	1,009.72
Other Income	53.98	56.61	44.55	187.79	14.24
Total Revenue	1,147.49	1,107.96	1,374.63	1,508.01	1,023.96
Changes in Inventories	86.53	49.16	-20.94	-60.35	-8.37
Cost of Material Consumed	212.51	265.88	421.36	459.46	310.32
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	0.00	0.00	0.00	0.00	0.00
Employee Benefits	198.30	135.23	108.58	100.48	76.23
Total Other Expenses	233.60	195.22	230.39	240.65	191.02
Manufacturing / Operating Expenses	153.90	136.61	171.65	173.19	133.79
Administrative and Selling Expenses	47.84	37.51	45.24	53.99	46.10
Other Expenses	31.86	21.10	13.50	13.46	11.13
Finance Costs	8.00	7.45	12.75	6.23	9.14
Depreciation and Amortization	57.20	54.60	43.10	39.10	31.64
Total Expenses	796.14	707.54	795.24	785.56	609.98
Profit Before Exceptional Items and Tax	351.35	400.42	579.39	722.45	413.98
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	351.35	400.42	579.39	722.45	413.98
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	351.35	400.42	579.39	722.45	413.98
Taxation	79.64	103.95	146.79	164.35	105.33
Current Tax	85.80	98.14	144.63	157.63	101.54
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-12.73	6.59	4.34	6.72	3.62
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	6.57	-0.78	-2.17	0.00	0.18
Profit After Tax	271.71	296.47	432.60	558.10	308.65
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	271.71	296.47	432.60	558.10	308.65
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	271.71	296.47	432.60	558.10	308.65
Earning Per Share - Basic	10.67	11.65	16.99	21.92	12.12
Earning Per Share - Diluted	10.62	11.65	16.99	21.92	12.12
Operation Profit before Depreciation	416.55	462.47	635.24	767.78	454.76
Operating Profit after Depreciation	359.35	407.87	592.14	728.68	423.12
Dividend Per Share	0.00	0.00	6.00	5.00	2.00
Dividend Percentage	0.00	0.00	600.00	500.00	200.00
Equity Dividend	0.00	0.00	152.74	127.28	50.91
Weighted Average Shares - Basic	25.46	25.46	25.46	25.46	25.46
Weighted Average Shares - Diluted	25.58	25.46	25.46	25.46	25.46